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Novel Mutation in FOXC1 Wing Region Causing
Axenfeld-Rieger Anomaly
Shirly G. Panicker,1 Srirangan Sampath,1 Anil K. Mandal,1 Aramati B. M. Reddy,1
Niyaz Ahmed,2 and Seyed E. Hasnain2,3,4
PURPOSE. To determine the possible molecular genetic defect
underlying Axenfeld-Rieger anomaly (ARA) and to identify the
pathogenic mutation causing this anterior segment dysgenesis
in an Indian pedigree.
METHODS. The FOXC1 gene was amplified from genomic DNA
of members of an ARA-affected family and control subjects
using four novel sets of primers. The amplicons were directly
sequenced, and the sequences were analyzed to identify the
disease-causing mutation.
RESULTS. A heterozygous novel missense mutation was identi-
fied in the coding region of the FOXC1 gene in all three
patients in this family. Consistent with the autosomal dominant
inheritance pattern, the mutation segregated with the disease
phenotype and was fully penetrant. The mutation was found in
the wing region of the highly conserved forkhead domain of
the FOXC1 gene and resulted in a very severe phenotype
leading to blindness.
CONCLUSIONS. This is the first study to demonstrate that a mu-
tation in the FOXC1 wing region can cause an anterior segment
dysgenesis of the eye. This mutation resulted in blindness in
the ARA-affected family, and the findings suggest that the
FOXC1 wing region has a functional role in the normal devel-
opment of the eye. Moreover, this is the first study from India
to report the genetic etiology of Axenfeld-Rieger anomaly.
Genotype–phenotype correlations of FOXC1 may help in es-
tablishing the disease prognosis and also in understanding the
clinical and genetic heterogeneity associated with various an-
terior segment dysgenesis caused by this gene. (Invest Oph-
thalmol Vis Sci. 2002;43:3613–3616)
The glaucomas are a group of heterogeneous disorders andare a major cause of blindness worldwide. Axenfeld-Rieger
anomaly (ARA) is a form of developmental glaucoma, caused
by the maldevelopment of the anterior segment of the eye.1 It
is inherited in an autosomal dominant fashion, and glaucoma
develops in 50% to 75% of the cases.2 It consists of a spectrum
of developmental defects of the anterior chamber of the eye,
with wide variability in expression. Ocular features in ARA
include prominent anterior Schwalbe’s line, abnormal angle
tissue, hypoplastic iris, polycoria, corectopia, and glaucoma.3
One gene for this disorder has been mapped to chromosome 6
in the p25 region.2 A few mutations in a forkhead/winged-helix
transcription factor gene FOXC1 (formerly known as FREAC3
and FKHL7) have been implicated in the pathogenesis of this
disorder.4,5
Although several cases of this disorder with varying severity
and manifestations have been identified in India, the genetic
etiology was unknown. Therefore an Indian pedigree with
multiple affected members in two generations was studied to
identify the genetic defect. We herein report the identification
of a novel wing mutation in the forkhead domain of the tran-
scription factor gene FOXC1 that causes the defect, the possi-
ble functional role, the diagnostic method developed, and the
genotype–phenotype correlation of the mutation.
METHODS
Clinical Evaluation and Patient Selection
The study protocol adhered to the tenets of the Declaration of Helsinki.
After providing informed consent, one clinically well-characterized
nonconsanguineous ARA-affected family with four members was re-
cruited for the study. This family was selected because it had three
affected members in two generations, and all family members were
available for the investigation. Patients and family members were
evaluated by a glaucoma specialist (AKM) and were followed up for 10
years. Father and both children were affected; the mother was not
affected. The clinical data and phenotypes of all three patients are
described in Table 1. Ophthalmic examinations included slit lamp
biomicroscopy, gonioscopy, measurement of intraocular pressure
(IOP) and visual acuity. This family did not exhibit any systemic
abnormalities, and no extraocular manifestations were seen.
Mutation Screening and Sequence Analyses
Because mutations in FOXC1 are known to cause ARA, the entire
coding region (1.6 kb organized in one exon)4 was screened for
mutations. DNA was extracted from the peripheral leukocytes of the
three patients, the mother, and the control subjects. Previous studies
had used either 9 or 12 sets of overlapping primers to amplify this
highly GC-rich gene.4,6,7 For mutation screening, these studies had
used either single-strand conformation polymorphism (SSCP) followed
by sequencing or direct sequencing of polymerase chain reaction
(PCR) products, with these sets of overlapping primers. In the present
study, mutation screening strategy was simplified by four novel sets of
overlapping primers developed by us. Using these primers (spanning
the entire exon), we amplified the FOXC1 gene in patients and control
subjects (Table 2). Amplicons were sequenced directly, and patient
and control sequences were compared, to identify all sequence
variations. The primers used and PCR conditions are described (Ta-
ble 2). The same sets of primers were used for PCR and bidirectional
sequencing.
All PCR reactions were done (PTC 200; MJ Research, Watertown,
MA), using 100 ng genomic DNA in 25-L reactions containing 1 PCR
buffer, 200 M of the dNTPs, 0.5 M of each primer, 10% dimethyl
sulfoxide (DMSO), and 1 U Taq polymerase (MBI Fermentas, Vilnius,
Lithuania). All PCR products were purified on separation columns
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(Amicon Microcon PCR; Millipore, Bedford, MA), terminator cycle
sequencing was performed (BigDye kit; Applied Biosystems, Foster
City, CA), and sequencing reactions were performed on an automated
DNA sequencer (ABI Prism 377; Applied Biosystems).
PCR-Restriction Fragment Length Polymorphism
Analysis and Cosegregation of Mutant Alleles
with Disease Phenotype
The novel mutation identified in this study resulted in loss of the NlaIII
recognition site. For determining the cosegregation of mutant alleles
with disease phenotype in the family, the respective fragment harbor-
ing the mutation was amplified from all family members, by using set
II of the primers (Table 2), and an aliquot of amplicon was digested
with NlaIII restriction enzyme (New England Biolabs, Beverly, MA).
The fragments were separated on 8% polyacrylamide gel, stained with
ethidium bromide, and visualized to distinguish the wild-type and the
mutant alleles. Sixty-one ethnically matched volunteer donors without
history of eye disorders served as control subjects.
Sequence Alignment
Multiple sequence alignment was performed by submitting various
forkhead protein sequences to the European Bioinformatics Institute
server. Alignment was performed with Clustal W software (provided in
the public domain by the European Bioinformatics Institute, Hinxton,
UK, and available at http://www2.ebi.ac.uk/clustalw).
RESULTS
Identification of a Novel Pathogenic Mutation in
the FOXC1 Wing Region
All three patients (the father and two children) in an ARA-
affected family had a heterozygous missense mutation (T3A
substitution) at 482 bp (cDNA position) in the highly con-
served forkhead domain of the FOXC1 transcription factor
gene. This mutation resulted in the change of amino acid
methionine to lysine at 161 amino acid position (M161K) in
FOXC1 and also abolished the NlaIII recognition site in the
DNA (Fig. 1). PCR-restriction fragment length polymorphism
(RFLP) analysis showed that mutant alleles segregated only
with the disease phenotype (Fig. 2) and not with the unaf-
fected mother and the control subjects analyzed. This mutation
was also absent in 61 ethnically matched control subjects (data
not shown). The mutated methionine residue has been con-
served across various species during evolution (Fig. 3).
The forkhead domain contains three  helices and two wing
regions. The respective amino acid positions in FOXC1 are 
helix-1: 83 to 93;  helix-2: 101 to 110;  helix-3: 119 to 132;
wing-1: 143 to 151 and wing-2: 155 to 176.8,9 Because the
amino acid change occurred at position 161, it is in the wing-2
region.
Genotype–Phenotype Correlations
Variable expression of the disease phenotype was noticed
between two affected generations of this family (Table 1). This
mutation resulted in a very severe phenotype in the father,
which, without prompt and early surgical intervention, led to
blindness. In contrast, the same mutation with early surgical
intervention in the children resulted in moderate severity and
reasonably good prognoses (Fig. 4).
DISCUSSION
This is the first study to demonstrate that a mutation in the
wing region of the forkhead/winged-helix transcription factor
gene FOXC1 can result in an anterior segment dysgenesis of
the eye, ARA. Therefore, the mutation reported herein is aTA
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novel one. Moreover, this is the fourth mutation in this gene
known to cause the ARA phenotype and the first study from
the Indian subcontinent to describe the molecular basis of
ARA. So far, only three FOXC1 mutations have been reported
to cause this disorder. These include a 10-bp deletion in the
upstream of the forkhead domain,4 a missense mutation
(Ile87Met),4 and a single nucleotide insertion5 in the 1 helix
region in the forkhead domain of this gene. Consistent with the
autosomal dominant inheritance, all three affected members
had one mutant allele segregating with the disease phenotype,
and the mutation was fully penetrant in the family.
Segregation of mutant alleles with the disease phenotype,
absence of mutant alleles in control subjects, and a high degree
of conservation of mutated residue across species during evo-
lution imply that the mutation we report is pathogenic. Al-
though various mutations in the FOXC1 gene have been impli-
cated in the pathogenesis of a spectrum of ocular disorders
such as Axenfeld anomaly, Axenfeld-Rieger syndrome, Rieger
anomaly, Iris hypoplasia, Peter’s anomaly, iridogoniodysgen-
esis type 1, ARA, and congenital glaucoma, none was found to
be in the wing region.4–8,10 Hence, this is the first wing
mutation known to cause any anterior segment dysgenesis
related to the FOXC1 gene.
FOXC1 is a member of the forkhead/winged-helix family of
transcription factors. These transcription factors contain a mo-
nomeric, 110-amino-acid DNA binding domain (forkhead do-
main) and have been conserved throughout evolution from
yeast to human.11,12 This DNA-binding motif is a variant of the
helix-turn-helix motif and consists of three  helices and two
large loops that form wing structures, W1 and W2.8,9,12 Amino
acids 155 to 176 of the forkhead domain constitute the wing-2
region.8,9 The mutation in this study was found in amino acid
position 161, within the wing-2 region (see the Results sec-
tion). So far, no other mutation has been reported in this
region. Therefore, this is the first mutation identified in the
wing-2 region of the FOXC1 transcription factor. The fork-
head/winged-helix family of transcription factors are essential
in a variety of developmental processes, including embryogen-
esis and tissue specific cell differentiation.11,12 It has been
reported that the W2 region of HNF- (a member of the
forkhead family of transcription factors) contacts with the
minor groove of DNA.9 Because FOXC1 is a transcription
factor, the W2 mutation could possibly affect the DNA–protein
interaction. Haploinsufficiency of forkhead transcription fac-
tors has been shown to cause aberrant ocular development.8,13
Considering these facts, it is tempting to speculate that this
mutation may affect the migration and/or differentiation of the
mesenchymal cells that contribute to the anterior segment of
the eye.13
TABLE 2. Novel sets of FOXC1 Primers and Conditions Used for Amplification
Primer Sets Used for Amplification (5-3)/Size
Position in cDNA
(bp)
Fragment Size
(bp)
MgCl2 Used
(mM)
Annealing
Temperature
(°C)
ARA1F - CCCGGACTCGGACTCGGC - 18 mer 93 to 76 429 1 62
ARA1R - AAGCGGTCCATGATGAACTGG - 21 mer 335–315
ARA2F - CCCAAGGACATGGTGAAGC - 19 mer 217–235 710 1 58
ARA2R - CTGAAGCCCTGGCTATGGT - 19 mer 926–908
ARA3F - ATCAAGACCGAGAACGGTACG - 21 mer 676–696 635* 1 58
ARA3R - GTGACCGGAGGCAGAGAGTA - 20 mer 1310–1291
ARA4F - TACCACTGCAACCTGCAAGC - 20 mer 1177–1196 517 1.25 58
ARA4R - GGGTTCGATTTAGTTCGGCT - 20 mer 1693–1674
PCR conditions for all primer sets: initial denaturation at 94°C for 3 minutes followed by (94°C for 30 seconds, annealing for 30 seconds), 72°C
for 45 seconds for 35 cycles, with final extension at 72°C for 7 minutes.
* Because of a nonspecific fragment, set 3 PCR fragment was eluted, diluted 1:10, and reamplified for sequencing, with 25 cycles.
FIGURE 1. Electropherogram of the sense strand of genomic DNA
from the ARA proband, showing a novel heterozygous missense mu-
tation. The heterozygous change 482 t3a (M161K) was present in the
mutant allele of the proband (B) and absent in the control (A). The
mutation (underscore and arrow) results in a change in amino acid at
codon 161.
FIGURE 2. PCR-RFLP analysis of cosegregation of the mutant allele
with the disease phenotype in an ARA pedigree. (f) Affected male
individuals; (E) unaffected female individual; arrow: proband. DNA
molecular weight marker (lane M) in base pairs (left); allele sizes
(right); control (lane C); mutant allele (small arrowheads), restriction
site change and mutation (nucleotide as well as amino acid changes)
are shown below the gel. The 710-bp FOXC1 amplification product
generated from the FOXC1 primer pair 2F/2R (Table 3) was cleaved by
NlaIII into five fragments of sizes 8, 40, 60, 156, and 446 bp in
unaffected individuals. The T482A mutation in the affected individuals
abolished the NlaIII site between the 156- and 446-bp fragments, and
the resultant 602-bp mutant allele segregates along with the disease
phenotype. The normal NlaIII cleavage products present in affected
individuals were generated from the wild-type FOXC1 allele in these
individuals. Fragments less than 446 bp are not shown in this 8%
polyacrylamide gel.
IOVS, December 2002, Vol. 43, No. 12 FOXC1 Wing Mutation in Axenfeld-Rieger Anomaly 3615
The abnormal eye development and the devastating pheno-
type (blindness in the father) in this family indicates that the
FOXC1 wing region has an important functional role in the
normal development of the eye (Fig. 4; Table 1). The geno-
type–phenotype correlation indicates that this mutation re-
sulted in blindness in the father (very severe phenotype and
very poor prognosis). The father had asymmetric manifesta-
tions in both eyes (the right eye became blind in childhood; the
left eye had very poor vision), whereas the children had uni-
form manifestations. Late surgical intervention in the father’s
left eye did not restore vision. Hypoplastic iris, polycoria, and
corectopia were present in the father, which indicated an
advanced stage of the disease. These manifestations were ab-
sent in the children (Table 1). The differences in clinical man-
ifestations between the two affected generations may be attrib-
utable to the age of surgical interventions—late surgery in the
father (24 years of age) and early surgery in the children (2–2.5
months)—or to the late diagnosis of the disease in father
(Table 1).
Several anterior segment dysgenesis show overlapping clin-
ical features and many are due to different mutations in the
FOXC1 gene.1,3–8,10 Hence, the clinical and genetic heteroge-
neity of anterior segment disorders can be understood better
with the accumulation of genotype data of the FOXC1 gene. It
may also help in the classification of these disorders as well as
in understanding the prognosis of the disease.
In sum, this study adds one novel mutation to the existing
spectrum of mutations that cause anterior segment dysgenesis
and also provides insight into the functional dissection of the
FOXC1 gene. The novel sets of primers used in this study have
simplified the mutation screening strategy of the FOXC1 gene.
This investigation also suggests that the FOXC1 gene is possi-
bly defective in other Indian ARA-affected families. However,
further analysis of ARA families is needed to establish the
genotype–phenotype correlations of this ocular disorder.
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FIGURE 4. Phenotypes of an ARA pedigree after surgery showing
varying prognosis. I.1 was the affected father with late surgical inter-
vention showing a very severe phenotype and a very poor prognosis
(blind in the right eye and very poor vision in the left eye). II.1 and II.2
were the affected children with early surgical intervention showing
clear corneas and reasonably good prognoses. Corneal edema com-
pletely cleared after surgery. Follow-up periods after surgery were I.1:
10 years, II.1: 4 years, and II.2: 3 years. For ages of surgical interven-
tions in affected members, refer to Table 1.
FIGURE 3. Multiple sequence alignment of human FOXC1 and related
FOX protein sequences. Bold letter with asterisk (*) and shading
represent the conserved residue methionine M161K (when mutated)
that causes the ARA phenotype. Right: sequence accession numbers.
The human FOXC1 sequence is underscored.
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